血液透析与腹膜透析治疗终末期糖尿病肾病疗效的比较研究  

Comparative Study on the Effect of Hemodialysis and Peritoneal Dialysis on End-Stage Diabetic Nephropathy

作　　者：刘盼盼 LIU Pan-pan(Liaoning Provincial People’s Hospital,Liaoning Shenyang 110000)

机构地区：[1]辽宁省人民医院,辽宁沈阳110000

出　　处：《中国医疗器械信息》2021年第20期61-62,共2页China Medical Device Information

摘　　要：目的:对血液透析与腹膜透析治疗终末期糖尿病肾病的临床疗效及预后情况进行分析。方法:选取自2017年12月~2019年11月在本院接受治疗的100例终末期糖尿病肾病患者,通过抽样的方法随机分成观察组与对照组,每组50例。其中对照组给予血液透析治疗,观察组给予腹膜透析治疗,对两组患者的临床治疗效果进行比较分析。结果:治疗后,观察组各项指标和病死率明显低于对照组(P<0.05),有统计学意义。结论:终末期糖尿病肾病患者在选择治疗方案时,应该充分结合患者的具体情况,给予有针对性的治疗方案,及时预防并治疗因糖尿病引发的多种并发症,以改善患者的生活质量,提升治疗效果。Objective:To analyze the clinical efficacy and prognosis of hemodialysis and peritoneal dialysis in end-stage diabetic nephropathy.Methods:100 end-stage diabetic nephropathy patients treated in our hospital from December 2017 to November 2019 were randomly divided into observation group and control group by sampling method,50 cases in each group.Among them,the control group was given hemodialysis treatment,the observation group was given peritoneal dialysis treatment,and the clinical treatment effect of the two groups was compared and analyzed.Results:After treatment,the indexes and mortality in the observation group were significantly lower than those in the control group(P<0.05),which was statistically significant.Conclusion:When choosing treatment plan,patients with end-stage diabetic nephropathy should give targeted treatment plan,prevent and treat many complications caused by diabetes in time,so as to improve the quality of life and improve the therapeutic effect.

关 键 词：血液透析 腹膜透析 

分 类 号：R587.2[医药卫生—内分泌]